Clinical Trials on Grade 2 Follicular Lymphoma
Total 1035 results
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingFollicular Lymphoma | Diffuse Large B-cell Lymphoma | CD19-positiveChina
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular LymphomaItaly
-
Clinica Universidad de Navarra, Universidad de...University of Navarrra Hospital (Clinica Universitaria); Center for Applied...UnknownFollicular Lymphoma | First Relapse/ProgressionSpain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
Portola PharmaceuticalsWithdrawnAITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
-
Schrödinger, Inc.RecruitingFollicular Lymphoma | Splenic Marginal Zone Lymphoma | Burkitt Lymphoma | Plasmablastic Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Non Hodgkin Lymphoma | Primary Effusion Lymphoma | DLBCL | High-grade B-cell Lymphoma | Primary Mediastinal... and other conditionsUnited States, Moldova, Republic of
-
Klaus Herfarth, MDRoche Pharma AG; German Low Grade Lymphoma Study GroupCompletedLymphoma, MalignantGermany
-
National Cancer Institute (NCI)TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
AmgenTerminatedMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B-cell Lymphoma(DLBCL)United States, Canada, Germany, Belgium
-
Hospices Civils de LyonUnknownFollicular Lymphoma | Genetic Predisposition to DiseaseFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHIV Infection | Unspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal... and other conditionsUnited States
-
Oslo University HospitalAarhus University Hospital; Hoffmann-La RocheRecruitingLymphoma, FollicularNorway, Finland
-
Incyte Biosciences Japan GKCompleted
-
SecuraBioWithdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheTerminatedLymphoma, FollicularGreece
-
Hoffmann-La RocheCompletedLymphoma, FollicularSpain, Sweden, Canada, Mexico, Czech Republic, France, Switzerland, Australia, Israel, Korea, Republic of, United Kingdom, Italy, Brazil, Finland, Russian Federation, Peru, Denmark, Argentina, Poland, Ecuador, Norway, Slovakia
-
Gemin XCompleted
-
M.D. Anderson Cancer CenterCureTech LtdCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Duke UniversityMillennium Pharmaceuticals, Inc.TerminatedLymphoma, FollicularUnited States
-
Icon Genetics GmbHCompleted
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited Kingdom
-
Lymphoma Study AssociationCompletedLymphomaFrance, Belgium
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma (DLBCL) | Follicular NHL Grade 3bHong Kong, Thailand, Sweden, Taiwan, Mexico, Austria, Serbia, China, Czech Republic, Australia, Malaysia, Croatia, Israel, South Africa, Bosnia and Herzegovina, Brazil, Bulgaria, Estonia, Latvia, Macedonia, The Former Yugoslav... and more
-
Grupo Oncológico para el Tratamiento y el Estudio...UnknownFollicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.Spain
-
MorphotekNational Cancer Institute (NCI); Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
University of Kansas Medical CenterCompletedNon-Hodgkins LymphomaUnited States
-
Incyte CorporationActive, not recruitingLymphomaUnited States, Spain, Italy, Israel, Poland, United Kingdom, Canada, Czechia, Germany, Denmark, Australia, Hungary, Sweden
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterGenentech, Inc.; BiogenCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminated
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
Lymphoma Study AssociationCompletedLymphoma, FollicularFrance, Italy
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedLymphoma, FollicularHungary
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., LtdNot yet recruitingChronic Lymphocytic Leukemia (CLL) | Peripheral T-cell Lymphomas (PTCL) | CD5+ Relapsed/Refractory Hematopoietic Malignancies | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL)
-
Hoffmann-La RocheCompletedLymphoma, B-Cell, Lymphoma, FollicularGermany
-
Biovest InternationalUnknown
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalUnknownFollicular Lymphoma | B Cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Plasma Cell Neoplasm | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Primary Cutaneous Follicle Centre LymphomaChina
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal... and other conditionsUnited States
-
Rush University Medical CenterGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated